Henk Verheul

Henk Verheul is a Full Professor in the Department of Medical Oncology at Erasmus MC, Erasmus School of Medicine. He is actively contributing to clinical and translational cancer research, with a focus on gastrointestinal malignancies and treatment optimization.

His research interests span a wide range of topics in oncology, including colorectal cancer, metastatic disease, immune checkpoint inhibitors, pharmacological resistance, and the use of digital health tools such as smartphone-based activity monitoring to predict clinical outcomes. He is also involved in precision medicine initiatives, particularly the application of whole genome sequencing in cancers of unknown primary origin.

The recent publications highlight a strong trend toward integrating advanced technologies—such as machine learning and genomics—into clinical oncology to improve patient stratification, treatment efficacy, and outcome prediction. His work bridges experimental pharmacology, clinical trials, and data science.

Henk Verheul actively collaborates with multidisciplinary teams, including the Dutch Pancreatic Cancer Group, and contributes to high-impact clinical research in solid tumors. His involvement in systematic reviews and real-world cohort studies underscores his commitment to evidence-based oncology practice.